Orthovita and Kensey Nash to Collaborate on New Spine Products

An agreement to commercialize new spine products based on biomaterials has been announced by Orthovita, Inc. (Malvern, PA, USA) and Kensey Nash Corp. (Exton, PA, USA).

In combination with proprietary biomaterials of Kensey Nash, the new products will build on the Vitoss technology of Orthovita. This is a highly porous, resorbable calcium phosphate scaffold that allows for resorption, cell seeding, and rapid in-growth of host bone. The products developed will be directed toward the spinal surgery market, the fastest growing market in orthopedics, according to the two companies. Kensey Nash will manufacture the products, while Orthovita will market and sell the products worldwide.

Kensey Nash has expertise and experience in designing, manufacturing, and processing absorbable biomaterials products for the cardiology, orthopedics, drug and biologics delivery, and wound care markets. Orthovita is a biomaterials company with proprietary technologies applied to the development of biostructures, synthetic biologically active tissue engineering products for restoration of the human skeleton, with a special focus on the spine.

"Kensey Nash's extensive material expertise, together with our own expertise in biomaterials, will yield many new and unique opportunities to create novel products for the spine market,” said Antony Koblish, president and CEO of Orthovita.





Related Links:
Orthovita
Kensey Nash